Latest News

The company had clocked a profit of Rs 6.85 crore in October-December FY23, according to a regulatory filing by the company now controlled by private equity firm Advent International.

Read More

​ The company had clocked a profit of Rs 6.85 crore in October-December FY23, according to a regulatory filing by the company now controlled by private equity firm Advent International. The company had clocked a profit of Rs 6.85 crore in October-December FY23, according to a regulatory filing by the company now controlled by private equity firm Advent International.  Moneycontrol Latest News Read More  

The company had clocked a profit of Rs 6.85 crore in October-December FY23, according to a regulatory filing by the company now controlled by private equity firm Advent International.

It had clocked a net profit of Rs 23 crore in the October-December period of FY23, the company said in an exchange filing.

Read More

​ It had clocked a net profit of Rs 23 crore in the October-December period of FY23, the company said in an exchange filing. It had clocked a net profit of Rs 23 crore in the October-December period of FY23, the company said in an exchange filing.  Moneycontrol Latest News Read More  

It had clocked a net profit of Rs 23 crore in the October-December period of FY23, the company said in an exchange filing.

NMDC Q3 results: The country’s largest iron ore producer#39;s profit rose 67% on a standalone basis.

Read More

​ NMDC Q3 results: The country’s largest iron ore producer#39;s profit rose 67% on a standalone basis. NMDC Q3 results: The country’s largest iron ore producer#39;s profit rose 67% on a standalone basis.  Moneycontrol Latest News Read More  

NMDC Q3 results: The country’s largest iron ore producer#39;s profit rose 67% on a standalone basis.

The drug firm had reported a PAT of Rs 232 crore in the year-ago period.

Read More

​ The drug firm had reported a PAT of Rs 232 crore in the year-ago period. The drug firm had reported a PAT of Rs 232 crore in the year-ago period.  Moneycontrol Latest News Read More  

The drug firm had reported a PAT of Rs 232 crore in the year-ago period.

The drug firm had reported a PAT of Rs 232 crore in the year-ago period.

Read More

​ The drug firm had reported a PAT of Rs 232 crore in the year-ago period. The drug firm had reported a PAT of Rs 232 crore in the year-ago period.  Moneycontrol Latest News Read More  

The drug firm had reported a PAT of Rs 232 crore in the year-ago period.

The drug firm had reported a PAT of Rs 232 crore in the year-ago period.

Read More

​ The drug firm had reported a PAT of Rs 232 crore in the year-ago period. The drug firm had reported a PAT of Rs 232 crore in the year-ago period.  Moneycontrol Latest News Read More  

The drug firm had reported a PAT of Rs 232 crore in the year-ago period.

The group said it expects a sales realisation of approximately Rs 7,500 crore from the project wherein the investment would be done via self-funding, bank financing and customer advances for bookings.

Read More

​ The group said it expects a sales realisation of approximately Rs 7,500 crore from the project wherein the investment would be done via self-funding, bank financing and customer advances for bookings. The group said it expects a sales realisation of approximately Rs 7,500 crore from the project wherein the investment would be done via self-funding, bank financing and customer advances for bookings.  Moneycontrol Latest News Read More  

The group said it expects a sales realisation of approximately Rs 7,500 crore from the project wherein the investment would be done via self-funding, bank financing and customer advances for bookings.

It had posted a net profit of Rs 9.74 crore in the October-December period of the preceding 2022-23 financial year, the company said in an exchange filing.

Read More

​ It had posted a net profit of Rs 9.74 crore in the October-December period of the preceding 2022-23 financial year, the company said in an exchange filing. It had posted a net profit of Rs 9.74 crore in the October-December period of the preceding 2022-23 financial year, the company said in an exchange filing.  Moneycontrol Latest News Read More  

It had posted a net profit of Rs 9.74 crore in the October-December period of the preceding 2022-23 financial year, the company said in an exchange filing.

It had clocked a net profit of Rs 903.89 crore in the year-ago period, the mining company said in an exchange filing.

Read More

​ It had clocked a net profit of Rs 903.89 crore in the year-ago period, the mining company said in an exchange filing. It had clocked a net profit of Rs 903.89 crore in the year-ago period, the mining company said in an exchange filing.  Moneycontrol Latest News Read More  

It had clocked a net profit of Rs 903.89 crore in the year-ago period, the mining company said in an exchange filing.

The project, that will have 2,372 luxury apartments, has a revenue potential of Rs 7,500 crore approximately. The ticket price of smallest apartment will be approximately Rs 3 crore while the largest ultra-luxury apartment is likely to cost around Rs 12 crore approximately.

Read More

​ The project, that will have 2,372 luxury apartments, has a revenue potential of Rs 7,500 crore approximately. The ticket price of smallest apartment will be approximately Rs 3 crore while the largest ultra-luxury apartment is likely to cost around Rs 12 crore approximately. The project, that will have 2,372 luxury apartments, has a revenue potential of Rs 7,500 crore approximately. The ticket price of smallest apartment will be approximately Rs 3 crore while the largest ultra-luxury apartment is likely to cost around Rs 12 crore approximately.  Moneycontrol Latest News Read More  

The project, that will have 2,372 luxury apartments, has a revenue potential of Rs 7,500 crore approximately. The ticket price of smallest apartment will be approximately Rs 3 crore while the largest ultra-luxury apartment is likely to cost around Rs 12 crore approximately.